Wildcat Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Editas Medicine
EDIT
|
+$6.51M |
| 2 |
Hilton Worldwide
HLT
|
+$4.95M |
| 3 |
Ares Capital
ARCC
|
+$2.41M |
| 4 |
New Mountain Finance
NMFC
|
+$2.18M |
| 5 |
Goldman Sachs BDC
GSBD
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$3.04M |
| 2 |
CoStar Group
CSGP
|
+$354K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Real Estate | 17.8% |
| 3 | Consumer Discretionary | 5.13% |
| 4 | Financials | 4.16% |
| 5 | Communication Services | 0.49% |
Similar funds
Wildcat Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Wildcat Capital Management held 27 positions worth $288M, down 19% from $354M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Wildcat Capital Management deployed $20.5M of net new capital in Q1 2016, opening 8 new positions and adding to 2 existing holdings. Its largest new stake was Editas Medicine: 247,768 shares worth $8.56M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Real Estate and Consumer Discretionary.
On the sell side, the largest reduction was CoStar Group, an estimated $354K trimmed.
- Wildcat Capital Management's largest Q1 2016 buy was Editas Medicine: 247,768 shares worth $8.56M.
- Wildcat Capital Management added most to Hilton Worldwide in Q1 2016, an estimated $4.95M increase.
- Wildcat Capital Management's biggest Q1 2016 reduction was CoStar Group, cutting an estimated $354K.
- Wildcat Capital Management fully exited iShares Biotechnology ETF in Q1 2016, selling an estimated $3.04M.
- Wildcat Capital Management's ten largest holdings make up 93% of its $288M portfolio in Q1 2016.
- Wildcat Capital Management opened 8 new positions and closed 5 in Q1 2016.
- Wildcat Capital Management's portfolio value fell 19% quarter-over-quarter to $288M.
Based on Wildcat Capital Management's 13F filing for Q1 2016, filed 13 May 2016.